Joachim Weischenfeldt
Overview
Explore the profile of Joachim Weischenfeldt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
5992
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gong T, Jiang J, Uthayopas K, Bornman M, Gheybi K, Stricker P, et al.
Nat Commun
. 2025 Mar;
16(1):2400.
PMID: 40064858
Prostate cancer (PCa) is highly heritable, with men of African ancestry at greatest risk and associated lethality. Lack of representation in genomic data means germline testing guidelines exclude for Africans....
2.
Plage H, Frericks A, Hofbauer S, Furlano K, Weinberger S, Rossner F, et al.
BMC Urol
. 2025 Feb;
25(1):37.
PMID: 39979991
Purpose: We aimed to assess the impact of GATA3 binding protein (GATA3) gene copy number alterations on tumor aggressiveness, patient prognosis, and GATA3 protein expression in a large urothelial bladder...
3.
Yamaguchi T, Houlahan K, Zhu H, Kurganovs N, Livingstone J, Fox N, et al.
Cancer Discov
. 2025 Feb;
PMID: 39945744
Newly diagnosed prostate cancers differ dramatically in mutational composition and lethality. The most accurate clinical predictor of lethality is tumor tissue architecture, quantified as tumor grade. To interrogate the evolutionary...
4.
Furlano K, Keshavarzian T, Biernath N, Fendler A, De Santis M, Weischenfeldt J, et al.
Int J Cancer
. 2025 Jan;
PMID: 39853587
Prostate cancer is a common malignancy that in 5%-30% leads to treatment-resistant and highly aggressive disease. Metastasis-potential and treatment-resistance is thought to rely on increased plasticity of the cancer cells-a...
5.
Kaastrup K, Tulstrup M, Hansen J, Schollkopf C, Raaschou-Jensen K, Orskov A, et al.
Haematologica
. 2025 Jan;
PMID: 39744828
Not available.
6.
Plage H, Furlano K, Hofbauer S, Rossner F, Schallenberg S, Elezkurtaj S, et al.
Int Urol Nephrol
. 2024 Dec;
PMID: 39680294
Purpose: Placental alkaline phosphatase (PLAP) is a protein with a poorly understood function that is normally only expressed in the placenta. In cancer, PLAP expression is a hallmark of germ...
7.
Furlano K, Plage H, Hofbauer S, Weinberger S, Ralla B, Fendler A, et al.
BJUI Compass
. 2024 Nov;
5(11):1081-1089.
PMID: 39539567
Objective: There is a shortage of established prognostic biomarkers in bladder cancer. One candidate is tumour protein 63 (p63), a transcription factor of the p53 gene family that is expressed...
8.
Kluth M, Hitzschke M, Furlano K, Plage H, Hofbauer S, Weinberger S, et al.
Genes Chromosomes Cancer
. 2024 Sep;
63(9):e23271.
PMID: 39324446
17p13 deletions including TP53 and other genes represent a common cause for reduced/lost p53 function in tumor cells. In this study, we analyzed the impact of 17p13 (TP53) deletions and...
9.
Harwood D, Pedersen V, Bager N, Schmidt A, Stannius T, Areskeviciute A, et al.
Nat Commun
. 2024 Sep;
15(1):7857.
PMID: 39251578
Glioblastoma remains one of the deadliest brain malignancies. First-line therapy consists of maximal surgical tumor resection, accompanied by chemotherapy and radiotherapy. Malignant cells escape surgical resection by migrating into the...
10.
Dubois F, Sidiropoulos N, Weischenfeldt J, Beroukhim R
Nat Rev Cancer
. 2024 Aug;
24(10):735.
PMID: 39103618
No abstract available.